Chapter Summaries

Jian Lianyun learned that a hospital-acquired MRSA outbreak had infected five ICU patients, including her elderly postoperative patient, and Wei Kang proposed using Three Purities’ Nano Pill. As the ICU struggled to treat the two critically ill patients, Director Cui agreed to revise the treatment plan and bring in the Nano Pills for clinical testing.

• Jian Lianyun told Wei Kang that five ICU patients had contracted MRSA and that her elderly patient was in grave condition.
• Wei Kang explained that Three Purities’ Nano Pill had shown promising results against bacterial infections in animal trials and offered to prepare it for the hospital.
• Director Cui reviewed the outbreak, as Xiao Fang and two other young patients recovered while two frail patients remained seriously ill despite antibiotics.
• Director Cui considered stronger antibiotics after Vancomycin and Linezolid proved insufficient for the two patients.
• Director Cui learned that Three Purities’ Nano Pill was entering human clinical trials and agreed to create a new treatment plan and request the pills.

Xue Kun brought Three Purities' Nano Pill to Director Cui's hospital to treat a patient with a severe lung infection, explaining how the algae-powered nanorobots carried and released antibiotics. After the patient's family signed the clinical trial consent form, Xue Kun and Director Cui prepared to administer the treatment.

• Director Cui welcomed Xue Kun from Three Purities, who delivered a refrigerated Nano Pill containing Tykoralin for the patient.
• Director Cui arranged for the patient's family to sign a clinical trial consent form before the new treatment was administered.
• Xue Kun explained how the algae-powered nanorobots could move through lung fluid, deliver antibiotics to an infection, and degrade after treatment.
• Director Cui learned that Xue Kun was a physicist and listened as he described the limits and possible future generations of nanorobots.
• A nurse told Director Cui that the family had signed the papers, and Xue Kun followed him toward the ICU with the Nano Pill.

Xue Kun and Director Cui treated two critically ill ICU patients with Nano Pills, and their fevers and inflammatory markers quickly fell. The Superbug infection was under control, though the patients still required monitoring and continued treatment.

• Director Cui and Xue Kun administered Nano Pill medication directly into the chest cavities of the two patients with severe lung infections.
• Xue Kun explained that the Nano Pill would release antibiotics near the lung lesions, and Director Cui arranged to monitor the patients for a day and continue treatment.
• At dinner, Xue Kun told Director Cui about his research background and his work at Three Purities.
• Nurse Li called to report that both patients' fevers had dropped to 37.8 degrees, so Director Cui and Xue Kun hurried back to the ICU.
• Director Cui checked the patients' blood tests and found that their White Blood Cell counts, Neutrophil Percentages, and C-reactive Protein levels had fallen, showing that the Superbug was under control.

Xue Kun’s Nano Pills cured two ICU patients infected with MRSA, saving Director Cui from the consequences of a hospital-acquired infection and completing the first human clinical trial. News of the treatment spread to other hospitals, accelerating interest in Nano Pills as a way to fight Superbugs and reduce antibiotic use.

• The two patients woke up, cleared their airways, and showed improved lung scans and inflammation markers after Nano Pill injections.
• Director Cui thanked Xue Kun for the treatment, while an Infection Control Department doctor blamed ICU hygiene practices and warned that the patients’ families might seek compensation.
• Director Cui learned that Bed Two’s patient had been Dr. Jian’s case, but the families accepted waived treatment fees and did not pursue the matter after the patients recovered.
• The patients came off ventilators and transferred to regular wards, concluding the first Human Clinical Trial of Nano Pills and preserving Director Cui’s position.
• News of Nano Pills’ success against MRSA spread among major hospitals, drawing interest from hospitals and patients with antibiotic-resistant infections.

Director Song explained how Sanqing’s Nano Pill saved a premature infant with antibiotic-resistant infections and warned that antibiotic overuse in livestock was contributing to drug resistance. At the company dormitory, Xue Shen encouraged Huang Qin to pursue a PhD, and Huang Qin began imagining a future as an academician.

• Director Song recalled how Sanqing’s Nano Pill delivered vancomycin and cured a premature infant resistant to seven antibiotics.
• Director Song warned a colleague that antibiotic residues in meat and eggs could pass drug resistance to newborns, while new antibiotics could not be developed quickly enough.
• Xue Shen finished the Nano Pill Phase II clinical trial report and planned to report it to President Wei before starting Phase III.
• Xue Shen shared his difficult PhD experience with Huang Qin over barbecue and praised Huang Qin’s research work.
• Xue Shen urged Huang Qin to consider pursuing a PhD to advance his career, and Huang Qin asked about an integrated program near the company.
• Huang Qin grew excited about earning a doctorate and imagined that his research ambitions might someday make him an academician.

After reviewing the Nano Pill trial report, Wei Kang became alarmed by antibiotic resistance linked to livestock and decided Sanqing should produce its own organic meat. He arranged to acquire disease-resistant pigs and chickens and build a farm and research center for internal supply.

• Wei Kang read the Nano Pill trial report and learned how widespread drug-resistant infections, including among babies, had become.
• Worried about antibiotic use in livestock and his family's future health, Wei Kang decided to establish a farm raising disease-resistant animals without growth-promoting antibiotics.
• Huang Qin told Wei Kang that disease-resistant pigs were already available and that researchers had developed a promising disease-resistant White Feather Chicken.
• Wei Kang asked Huang Qin to contact New Hope and the Academy of Agricultural Sciences to purchase breeding stock, then told Sun Chengren to find a suitable site for an organic farm and research center.
• Sun Chengren agreed to oversee the project, and Wei Kang said Sanqing would use genetic research to produce reliable, pollution-free food for its employees and families.

After years of building a hopeful life despite paralysis, Zhu Jun fell critically ill with a severe, highly drug-resistant Pseudomonas aeruginosa infection. As his condition worsened and doctors struggled to find a safe treatment, Zhu Ming decided to ask Zhu Jun’s online fans to help locate experts.

• Zhu Jun recalled his accident, years of despair, and eventual recovery of purpose through gaming and online content creation as doctors rushed him into emergency care.
• Dr. Zhao admitted Zhu Jun to the ICU after he lost consciousness, then suspected a Pseudomonas aeruginosa infection that had spread from his urinary tract to his lungs.
• Laboratory tests showed the infection resisted nearly every antibiotic, leaving Polymyxin as a possible option despite its serious kidney risks.
• A nurse told Dr. Zhao that Zhu Jun was already showing signs of kidney failure, prompting him to seek an expert consultation.
• Dr. Zhao explained Zhu Jun’s grave condition to Zhu Ming, who decided to use his brother’s online following to find medical experts who could help.

Zhu Jun’s brother appealed online for expert help as doctors discovered that a drug-resistant Pseudomonas aeruginosa infection had left Zhu Jun critically ill. Xue Shen brought Three Purities’ Nano Pills to the hospital, and the doctors began combination treatment with Polymyxin and Tigecycline.

• Zhu Ming posted a video explaining Zhu Jun’s critical condition and asking specialists to come to Zhejiang Provincial People's Hospital.
• Doctors at the hospital found that Zhu Jun’s Pseudomonas aeruginosa carried the NDM-1 resistance gene and discussed using Polymyxin with Tigecycline.
• The ICU director proposed using Three Purities’ Nano Pills to deliver smaller antibiotic doses while reducing liver and kidney toxicity.
• Xue Shen arrived with Nano Pills and showed Dr. Zhao how to load them with Polymyxin and Tigecycline at the hospital.
• The ICU director injected both Nano Pill solutions into Zhu Jun’s veins as the department heads watched.

After Sanqing Group’s Nano Pills helped save Zhu Jun from a drug-resistant infection, he regained consciousness and found hope that future technology might treat his high paraplegia. Meanwhile, Cleveland Clinic director Dr. Harrison arranged for a team of experts to travel to China and observe Nano Pill treatments.

• Zhu Ming posted a video announcing that Zhu Jun had regained consciousness and crediting Sanqing Group’s Nano Pills and antibiotic treatment with saving him.
• Netizens discussed a report explaining how Nano Pills deliver antibiotics to infections, and the technology became widely popular.
• Zhu Jun learned how close he had come to death, then went outside in his wheelchair and resolved to live for the eight years remaining on his original prognosis while hoping for a treatment.
• Dr. Harrison presented a Nano Pill clinical trial paper and a report about Zhu Jun’s case to Cleveland Clinic experts, who praised the treatment’s potential.
• Dr. Harrison told the experts that they would travel to China in two days to observe Phase III Nano Pill trials in Kun City.

Director Fang welcomed Dr. Harrison and twelve department heads from Cleveland to Kun City First People's Hospital, where they negotiated an exchange that let the visitors join Three Purities' Clinical Trials in return for teaching and clinical work. The visitors began learning about the hospital’s advanced treatments, and Dr. Roman answered Dr. Jian’s question about brainstem hemorrhage surgery.

• Director Fang greeted Dr. Harrison and the Cleveland delegation at the hospital, then led them on a tour of its outpatient, emergency, ICU, and surgical facilities.
• Director Fang privately planned to delay the visitors’ access to the Clinical Trials until Phase III and make the exchange benefit the hospital’s staff.
• At a meeting, Director Fang offered the delegation access to ongoing Clinical Trials in exchange for daily outpatient consultations, a demonstration surgery, and a lecture.
• Dr. Harrison agreed to the conditions, and Director Fang arranged for the visitors to begin learning about Artificial Blood, Nano Pills, and capsule gastrointestinal endoscopy that afternoon.
• Dr. Jian asked Dr. Roman about neuroendoscopic surgery for brainstem hemorrhage, and Dr. Roman described precise localization and careful hematoma removal as key steps.

Jian Lianyun impressed the Cleveland Clinic visitors with her neurosurgical experience, and they were amazed by Kun City First People's Hospital's capabilities and Nano Pills. Meanwhile, Grandpa Zhang and his son accepted a bypass operation after a consultation with Director Gao and Dr. Charlie, then left proud to have secured treatment from a renowned foreign surgeon.

• Jian Lianyun told Dr. Roman that she had already performed seven or eight of the challenging surgeries, astonishing him and the other Cleveland visitors.
• Director Fang and the hospital staff exchanged medical knowledge with the visitors, who admired the hospital's clinical strength and watched Nano Pills being loaded with drug molecules.
• Grandpa Zhang and his son learned that Cleveland Clinic experts were consulting at the hospital and met Director Gao and Dr. Charlie for a cardiac assessment.
• Director Gao and Dr. Charlie recommended bypass surgery for Grandpa Zhang's severe coronary disease, and his son persuaded him to accept the operation despite its cost.
• Grandpa Zhang and his son saw Dr. Charlie's résumé and proudly told other patients that they had arranged for the foreign expert to help perform the surgery.

Jian Lianyun persuaded a hesitant family to consent to emergency surgery for a massive brainstem hemorrhage, then led a five-and-a-half-hour operation that saved the patient. Dr. Roman revealed that Jian had performed the surgery herself, and the family apologized and thanked her.

• Jian Lianyun and Dr. Roman assessed the unconscious patient’s eleven-milliliter brainstem hemorrhage and determined that emergency surgery was necessary.
• The patient’s sister-in-law opposed the operation and wanted to wait for an expert from Sea City, but Jian Lianyun gained the family’s consent by invoking Dr. Roman’s expertise.
• Jian Lianyun led the operation and, when suction could not remove the clotted hematoma, followed advice to extract it bit by bit with forceps.
• After the successful surgery, Dr. Roman told the family that Jian Lianyun had performed the operation and praised her skill.
• The family thanked Jian Lianyun, and the patient’s sister-in-law apologized for doubting her.

At Kun City First People's Hospital, Cleveland Clinic experts praised the Nano Pill and Three Purities's Artificial Blood while discussing antibiotic resistance and medical advances. Dr. Harrison secured long-term cooperation with Director Fang, and the foreign experts left after helping raise the hospital's profile and attract patients.

• A patient with multidrug-resistant Acinetobacter baumannii recovered after treatment with antibiotics carried by the Nano Pill and moved from the ICU to a regular ward.
• Dr. Hank explained that antibiotic resistance was worsening worldwide, while Dr. Harrison and Dr. Roman argued that continued scientific progress could still bring victories against bacteria.
• The doctors praised Three Purities's Artificial Blood and discussed its potential to lead to artificial organs, while Dr. Roman commended Dr. Jian's surgical skill.
• Dr. Harrison revealed that Dr. Jian was Mr. Wei's wife and presented a cooperation agreement with Director Fang to send two groups of Cleveland Clinic doctors to Kun City each year.
• Dr. Roman praised Chinese hospitals for exposing doctors to complex cases and broader training, and the experts discussed establishing a lasting exchange between the hospitals.
• The Cleveland Clinic experts departed after the cooperation drew publicity, patients, and funding for Kun City First People's Hospital, and Academician Fang hosted a farewell banquet and saw them onto their plane.

Wei Kang reviewed Three Purities' financial results and celebrated that the company had become the pharmaceutical industry's second-largest by revenue, while planning to overtake Johnson & Johnson. He remained confident that Three Purities' expanding drug and medical equipment businesses would sustain its growth.

• Wei Kang reviewed Three Purities' annual report, which showed revenue reaching $78.2 billion, driven especially by medical equipment.
• Wei Kang saw HIV drug sales growth disappear and expected the business to decline as patients were cured, but trusted Three Purities' other medicines and research pipeline to keep the company growing.
• Wei Kang compared quarterly reports and laughed that Gilead's anti-AIDS market was shrinking even faster than Three Purities'.
• Wei Kang celebrated that Three Purities' total revenue had surpassed Pfizer's and ranked second in the pharmaceutical industry, behind Johnson & Johnson.
• Wei Kang predicted that Three Purities would strengthen its medical equipment business and overtake Johnson & Johnson for first place.

Wei Kang spent his accumulated system points on an Artificial Heart, an Ultrasonic Scalpel, a Bionic Blood Vessel, and a Bionic Painless Syringe. He then extracted five useful side effects from discarded prescriptions, leaving himself with new drug-development prospects.

• Wei Kang checked the System Mall and confirmed that he had 13,520,062 points.
• Wei Kang exchanged ten million points for an Artificial Heart after weighing it against other artificial organs.
• Wei Kang spent more points on an Ultrasonic Scalpel, a Bionic Blood Vessel, and a Bionic Painless Syringe.
• Wei Kang searched discarded prescriptions and selected five side effects that could be repurposed into treatments.
• Wei Kang extracted the five side effects for potential drugs targeting Chronic Nephritis, oxidative damage, asthma, high blood sugar, and inflammation.

Wei Kang planned Three Purities’ next medical-device and drug projects, settling on Oral Insulin as a major target for its nanotechnology research. The chapter ended with Wei Kang and Jian Lianyun celebrating the New Year with her family and discussing having children.

• Wei Kang reviewed Three Purities’ medical-device ambitions, including nanorobots, artificial organs, MRI equipment, and surgical robots.
• Wei Kang conceived an Oral Insulin project that would use nanoparticles to deliver insulin through the intestinal wall to the liver, and decided to launch it after the New Year.
• Wei Kang considered whether Xue Shen and the Nano Laboratory could handle the project, then assigned research priorities and decided to establish an artificial organ laboratory.
• Wei Kang brought Jian Lianyun’s family to Sanqing Garden for New Year’s Eve, where they celebrated together.
• Wei Kang suggested that he and Jian Lianyun have several children, and Jian Guohua revealed he had overheard them and enthusiastically agreed.

Jian Lianyun agreed to have a child with Wei Kang, and after the New Year Wei Kang approved Three Purities’ Oral Insulin project. Xue Shen and Gu Xian outlined ways to solve the drug-delivery challenges, leaving Wei Kang confident that the project could succeed.

• Jian Lianyun agreed to start preparing for pregnancy, and she and Wei Kang spent the Spring Festival researching preparations and buying supplements.
• After the holiday, Wei Kang appointed Xue Shen to lead the Oral Insulin project, and Xue Shen proposed using Nanoparticles to protect insulin and carry it through the intestinal wall.
• Xue Shen reported that Nano Pill trials were succeeding against Superbugs and warned that rising antibiotic resistance could create an opportunity for Three Purities.
• Wei Kang brought Gu Xian into the project, and Gu Xian described Absorption Promoters, including Chitosan and Cell-Penetrating Peptides, as ways to improve insulin absorption.
• Wei Kang became confident that the Oral Insulin project would eventually succeed.

Wei Kang launched projects for artificial hearts, artificial blood vessels, and other medical products, while discussing their technology and potential pricing with Lu Tingfeng. Sun Chengren returned from vacation with news that he had found a farm suitable for raising livestock and producing organic ingredients.

• Wei Kang told Lu Tingfeng to begin development of several medical device projects, including artificial hearts and artificial blood vessels.
• Lu Tingfeng reviewed the device designs and discussed the artificial heart’s potential price and the biomimetic painless syringe with Wei Kang.
• Lu Tingfeng left excited to advance the projects, and Wei Kang worried that he might overwork himself again.
• Sun Chengren visited Wei Kang, congratulated him on preparing to have a child with Lian Yun, and gave him news that he had found a suitable farm.

Wei Kang and Sun Chengren established Sanqing Farm on nearby mountain land, outfitted it with automated equipment, and hired Xie Hui to oversee animal care and feed. After learning that its piglets and chicks had been genetically modified for disease resistance, Xie Hui realized the farm was more advanced than he had expected.

• Wei Kang approved Sun Chengren’s proposed mountain site and planned a modest organic farm focused on research, with pigs and chickens raised using automated equipment.
• Wei Kang and Sun Chengren inspected the site, confirmed the lease, and prepared to renovate the former pig farm and bring in piglets and chicks.
• Xie Hui arrived to start work, and Sun Chengren showed him the automated pigsties, free-range chicken coops, and farm facilities.
• Sun Chengren assigned Xie Hui responsibility for buying and formulating organic feed, while explaining that other medicines and vaccines could be used when needed.
• Sun Chengren told Xie Hui that the arriving piglets and chicks had been genetically modified with disease-resistant genes, leaving Xie Hui astonished by the farm’s technology.

Xie Hui joined Three Purities’ agricultural research farm and learned about its genetically modified pigs and chickens from Huang Qin. Huang Qin gave him Lycopene Rice, which Xie Hui hoped could help his ailing father, as their partnership began.

• Xie Hui inspected thirty disease-resistant sows and met Huang Qin, who introduced a genetically modified Devil Muscle Pig.
• Huang Qin explained the muscle pigs’ health problems and the research plan to cross them with disease-resistant pigs for improved meat production.
• Xie Hui helped settle fifty disease-resistant White Feather Chickens and fifty gene-edited Sanhuang Chickens, quickly recognizing that they were hungry.
• Huang Qin gave Xie Hui a box of Lycopene Rice and described its potential health benefits.
• Xie Hui thought of his father’s health problems, treasured the rice, and told Huang Qin he was like a real brother.